Table 5.
KEGG Pathways | Pulmonary Insufficiency at 1 mo | Pulmonary Insufficiency at 3 mo |
---|---|---|
Metabolism (glycolysis, TCA cycle, amino acid, ATP transporters) | ↓ | ↓ |
Cell cycle | ↓ | ↓ |
Calcium signaling | ↓ | ↓ |
GPCR signaling | ↓ | ↓ |
Wnt signaling | ↓ | ↓↑ |
MAPK signaling | ↓ | ↓↑ |
Degradation | ↓ | ↓↑ |
Cell adhesion | ↓ | ↓↑ |
TGF-β signaling | ↓ | ↑ |
p53 signaling | ↓ | ↑ |
Cytoskeleton | ↓ | ↑ |
Repair of damaged DNA | — | ↓ |
Regulation of transcription | — | ↓ |
Ion channel activity | — | ↓ |
NK cell-mediated cytotoxicity | — | ↓ |
Insulin, mTOR signaling | — | ↑ |
Adiopocytokine signaling | — | ↑ |
Many of the pathways downregulated at 1 mo were also downregulated at 3 mo. No pathways were significantly upregulated at 1 mo. TGF-β and p53 signaling and c pathways related to the cytoskeleton were downregulated at 1 mo but demonstrated upregulation by 3 mo. Pathways related to Wnt, MAPK, degradation, and cell adhesion were downregulated at 1 mo. Over time, these pathways demonstrated areas of up- and downregulation. Several novel pathways became significant at 3 mo including insulin and adipocytokine signaling.